等待開盤 03-26 09:30:00 美东时间
-0.020
-0.22%
今日重点评级关注:HC Wainwright & Co.:维持Altimmune"买入"评级,目标价从12美元升至25美元;BTIG:维持Jade Biosciences"买入"评级,目标价从28美元升至39美元
03-17 11:45
Zevra Therapeutics Inc. shares are trading higher on Monday after it agreed to sell its SDX Portfolio to Commave for $50 million.
03-16 21:26
VYGR飙升21%,Q4亏损收窄及销售额超预期;Figure大涨超20%,进军汽车贷款市场获华尔街唱多;Stagwell涨逾17%,引入AppLovin先进的移动广告平台>>
03-11 16:04
Zevra Therapeutics jumped in Tuesday premarket trading after partnering with GeneDx to expand NPC genetic testing and reporting fourth-quarter earnings and revenue that beat estimates.
03-11 02:45
Gainers Zevra Therapeutics (NASDAQ:ZVRA) stock moved upwards by 20.6% to $11.0...
03-10 05:05
Zevra Therapeutics shares are trading higher after the company reported better-...
03-10 04:14
The Q4 earnings report for Zevra Therapeutics (NASDAQ:ZVRA) was released on Mon...
03-10 04:12
Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.05 by 280 percent. This is a 128.36 percent increase over losses of $(0.67) per share from
03-10 04:10
Companies Reporting Before The Bell • ZIM Integrated Shipping (NYSE:ZIM) is exp...
03-09 19:11
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced the appointment of Justin Renz as Chief
03-05 20:30